48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease
A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease
A Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)
A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3)
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease
A Phase 3 Study of NE3107 in Probable Alzheimer's Disease
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011)
A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease
A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease
A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants
A Study of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
A Study of Seltorexant in Participants With Probable Alzheimer's Disease
A Study of the Effects of CY6463 in Participants With Alzheimer's Disease With Vascular Pathology
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease Dementia (ADEPT-1)
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Accelerated Non-Atherosclerotic Brain Arterial Aging Relationship to Alzheimer's Disease
Acute Exercise and the Cerebral Metabolic Response in Aging and Alzheimer's Disease
ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevate
Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease
Alzheimer's Disease and Precision Medicine Research Among Native People
Alzheimer's Disease Core Center
Alzheimer's Disease Genetics Study
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension
APOE in the Predisposition to, Protection From, and Prevention of Alzheimer's Disease
Arizona Alzheimer's Disease Research Center (ADRC)
ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease
Auricular Point Acupressure to Manage Pain in Patients With Alzheimer's Disease and Related Disorders
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
Brain Boosters 2 in Persons at Risk for Alzheimer's Disease: a Digital Application Supported Intervention
Brain Energy for Amyloid Transformation in Alzheimer's Disease Study
Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer's Disease
Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease
Collaborative Care Coordination Program for Alzheimer's Disease and Related Dementias
Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease
Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease)
Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease
Development of Novel Measures for Alzheimer's Disease Prevention Trials
Diagnosis of Alzheimer's Disease Using Event Related Potentials
Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease
Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals Wit
Down Syndrome Clinical Trials - Study of Alzheimer's Disease in Down Syndrome
Early Onset Alzheimer's Disease Genomic Study
Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks
Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease
Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)
Enhancing Memory in Mild Cognitive Impairment and Early Stage Alzheimer's Disease
Escitalopram for Agitation in Alzheimer's Disease
Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
Exercise for Brain Health in the Fight Against Alzheimer's Disease
F 18 T807 Tau PET Imaging of Alzheimer's Disease
First-in-human Evaluation of EAAT2 PET Tracer in Healthy and Alzheimer's Diseased Brain
Gamma Induction for Alzheimer's Disease
Gene Therapy for APOE4 Homozygote of Alzheimer's Disease
Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease
GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)
Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease
Home-based tDCS for Apathy in Alzheimer's Disease
Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA)
Improving Sleep and Cognition in Alzheimer's Disease
Individualized Brain Stimulation to Improve Mobility in Alzheimer's Disease
Information About Alzheimer's Disease for Latinos in New York City
Interventions for Patients With Alzheimer's Disease and Dysphagia
Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease?
Late Onset Alzheimer's Disease
Light and the Effect on Metabolic Syndrome and Alzheimer's Disease
Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2
Lomecel-B Effects on Alzheimer's Disease
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
Microglial Activation Positron Emission Tomography (PET) Brain Imaging in Multiple Sclerosis and Alzheimer's Disease
Molecular and Structural Imaging in Atypical Alzheimer's Disease: A Longitudinal Study
Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease
Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects
Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
Musical Engagement of Brain Lobes in Alzheimer's Disease Patients Study
Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease
Network-guided TMS in Early Alzheimer's Disease
Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial
NeurostImulation for Cognitive Enhancement in Alzheimer's Disease
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
NP001, Alzheimer's Disease, and Blood Markers of Inflammation
OCTA in Mild Cognitive Impairment and Alzheimer's Disease
Old SCHOOL Hip-Hop: Improve Alzheimer's Disease Knowledge
Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease
Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease
Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease Prevention
Physical Activity, Alzheimer's Disease and Cognition Relative to APOE Genotype
Pilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's Disease
Plasma Hydrogen Sulfide as a Biomarker for Alzheimer's Disease and Related Dementias
Preclinical Imaging Biomarkers of Alzheimer's Disease Neuropathology in Young Adults With Youth-onset Diabetes: a Proof-of-concept Study
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Quetiapine for the Treatment of Insomnia in Alzheimer's Disease
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"
Rhythmic Light Therapy for Alzheimer's Disease Patients
Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study
Ryan Companion Robot for Assisting Elderly People With Alzheimer's Disease
Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease
Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease
Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Aduhelm Therapy
Safety, Tolerability and Pharmacokinetics of CMS121, a Drug Candidate for Alzheimer's Disease, in Healthy Subjects
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD)
Senicapoc in Alzheimer's Disease
Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease
Sirtuin-NAD Activator in Alzheimer's Disease
Sleep Trial to Prevent Alzheimer's Disease
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease
Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls
Study of the Effect of Repetitive Transcranial Magnetic Stimulation on Language in Patients With Alzheimer's Disease
Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease
Study to Evaluate Coconut Oil for Alzheimer's Disease
Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease
SUPPORT-D Intervention for Persons With Alzheimer's Disease and Their Caregivers
Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone
Telerehabilitation Alzheimer's Disease Feasibility (TADF)
Thalidomide for Patients With Mild to Moderate Alzheimer's Disease
The Revitalize Study in Older Adults at Risk for Alzheimer's Disease
The Use of Memantine for Prevention of Alzheimer's Disease
The Wandering Nerve: Gateway to Boost Alzheimer's Disease Related Cognitive Performance
Therapeutic Diets in Alzheimer's Disease
Time-in-bed Restriction in Older Adults With Sleep Difficulties With and Without Risk for Alzheimer's Disease
Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer Disease
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)
Transmagnetic Stimulation Pilot in Early Stage Alzheimer's Disease
Traumatic Brain Injury and Alzheimer's Disease/Related Dementias Caregiver Support Intervention
Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease
UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy
UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy
Using Technology to Support Care Partners for Persons With Alzheimer's Disease: Tele-STELLA
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
Vestibular Therapy in Alzheimer's Disease
Wake Forest Alzheimer's Disease Clinical Core